Nomura Holdings Inc Amicus Therapeutics, Inc. Transaction History

Nomura Holdings Inc

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2019 Nov 14, 2019	SELL	$8.02 - $13.25 $661,650 - $1.09 Million	-82,500 Closed	0 $0
Q2 2019 Aug 14, 2019	BUY	$10.96 - $14.4 $904,200 - $1.19 Million	82,500 New	82,500 $1.03 Million
Q2 2018 Aug 14, 2018	SELL	$13.13 - $17.09 $7.62 Million - $9.92 Million	-580,260 Closed	0 $0
Q1 2018 May 14, 2018	SELL	$13.76 - $17.12 $1.59 Million - $1.97 Million	-115,200 Reduced 16.56%	580,260 $8.68 Million
Q1 2018 May 14, 2018	BUY	$13.76 - $17.12 $7.98 Million - $9.93 Million	580,260 Added 503.7%	695,460 $10.3 Million
Q4 2017 Feb 14, 2018	SELL	$12.51 - $16.24 $950,760 - $1.23 Million	-76,000 Reduced 39.75%	115,200 $1.65 Million
Q3 2017 Nov 14, 2017	BUY	$11.74 - $15.78 $2.24 Million - $3.02 Million	191,200	191,200 $2.89 Million

313

314M

516K

833K

Ticker FOLD
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 280,497,984
Market Cap $2.8B
Description
Amicus Therapeutics, Inc., a biotechnology company, focuses on discovering, developing, and delivering medicines for rare diseases. Its commercial product and product candidates include Galafold, an oral precision medicine for the treatment of adults with a confirmed diagnosis of Fabry disease and an amenable galactosidase alpha gene variant bas...

Get notified when there are updates to the investment portfolio of Nomura Holdings Inc, based on Form 13F filings with the SEC.

Stay updated on Nomura Holdings Inc with notifications on news.